SL Science Holding Ltd

SLBT chart

SL Science Holding Ltd news

• SL Science H1FY26 Results: Revenue rises 23% to $1.39 million

  scanx.trade · Oct 26, 4:46 PM EDT

• SL Science Holding Limited Reports First Half 2026 Financial Results

  Yahoo Finance · Oct 26, 4:15 PM EDT

• SL Science Holding Limited Estimates – NASDAQ:SLBT

  TradingView · Oct 23, 8:48 PM EDT

• SL Science Holding Limited (SLBT) Company Profile & Facts - Yahoo Finance

  Yahoo! Finance Canada · Oct 23, 4:00 PM EDT

• SL Science Presents Preclinical Data at the 85th Annual Meeting of the Japanese Cancer Association Showing γδ T Cells Target Chemotherapy-Resistant Glioblastoma

  Yahoo Finance · Sep 24, 8:00 AM EDT

• SL Science Holding Limited Rings Nasdaq Bell, Capping an Active First Quarter as a Publicly Traded Company

  Yahoo Finance · Sep 2, 4:10 PM EDT

• SL Science Highlights New FDA Drug Master File for GDT Cell-Derived Exosomes, Expanding the Regulatory Foundation of its Platform

  Yahoo Finance · Aug 27, 8:00 AM EDT

• SL Science Holding (SLBT) Stock May Be Fully Priced Even After A 74% Fall

  Yahoo Finance · Aug 18, 1:13 PM EDT

• SL Science Leadership Co-Authors Peer-Reviewed Framework for Clinical Development of γδ T Cell Therapy in Glioblastoma

  Yahoo Finance · Aug 11, 8:00 AM EDT

• SL Science Announces Successful Exhibition of Breakthrough Brain Cancer Therapy Research at the 2026 World Congress of Basic and Clinical Pharmacology

  Yahoo Finance · Jul 17, 8:00 AM EDT

• Sector Update: Healthcare Stocks Decline Late Afternoon

  Yahoo Finance · Jul 10, 3:50 PM EDT

• SL Science Holding Limited Submits Orphan Drug Designation Request to the U.S. FDA for GDT Cell Therapy Targeting Glioblastoma

  Yahoo Finance · Jul 10, 8:00 AM EDT

SL Science Holding Ltd key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-K6-K2026-10-26
• 6-KFORM 6-K2026-09-24
• 6-KFORM 6-K2026-09-01
• 6-KFORM 6-K2026-08-27
• 6-KFORM 6-K2026-07-10
• 20-FANNUAL REPORT2026-06-18
• 6-KFORM 6-K2026-06-15

About SL Science Holding Ltd

Ticker

SLBT (Nasdaq)

Industry

Biological Products, (No Diagnostic Substances)

Headquarters

Taipei City

Incorporated in

Cayman Islands

Fiscal year end

December 31

SEC CIK

2070534

Frequently asked questions